[144] Procter & Gamble Company SEC Filing

Rhea-AI Filing Summary

Procter & Gamble Company (PG) Form 144 notice: The filer notified intent to sell 10,686 shares of Procter & Gamble common stock through Morgan Stanley Smith Barney on 08/19/2025 on the NYSE. The filing lists an aggregate market value of $1,655,314.83 and reports 2,342,371,488 shares outstanding. The shares to be sold were acquired on 08/18/2025 under a Performance Stock Program Award from The Procter & Gamble Company; the acquisition quantity is reported as 22,496 shares with payment on 08/18/2025. The filer attests there is no undisclosed material adverse information and includes the standard signature and criminal-penalty notice applicable to Form 144.

Positive

• Compliance disclosure: The filer submitted a Form 144 with broker, share amount, aggregate market value, and sale date as required.
• Transaction detail: Acquisition method and date (Performance Stock Program Award on 08/18/2025) are explicitly stated.
• Broker and market identified: Morgan Stanley Smith Barney and NYSE are named for the proposed sale.

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine Rule 144 sale notice disclosing a small issuance and planned sale with full transaction details.

The filing is a standard Form 144 reporting a proposed resale of 10,686 Procter & Gamble shares through Morgan Stanley Smith Barney with an aggregate value of $1,655,314.83. It specifies the shares were acquired the prior day via a Performance Stock Program Award (22,496 shares acquired 08/18/2025). The notice also confirms no securities of the issuer were sold by the reporting person in the past three months. For investors, this document simply documents compliance with Rule 144 resale requirements and provides quantity, price aggregate, broker, and acquisition details.

Corporate Governance Expert

TL;DR: Filing meets disclosure obligations; includes standard attestation on material information.

The Form 144 provides the necessary procedural disclosures: class of security, broker identification, number of shares to be sold, aggregate market value, acquisition date and nature (Performance Stock Program Award), and the issuer share count. The signer makes the required representation that no undisclosed material adverse information exists. There are no reported sales in the prior three months. From a governance perspective, this filing appears complete for a Rule 144 transaction.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 38th Floor New York NY 10004	10686	1655314.83	2342371488	08/19/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/18/2025	Performance Stock Program Award	The Procter & Gamble Company			22496	08/18/2025	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What securities does the Form 144 for PG propose to sell?

The notice proposes sale of 10,686 shares of Procter & Gamble common stock.

When is the proposed sale date listed on the Form 144 for PG?

The proposed sale date is 08/19/2025.

How were the shares being sold acquired according to the filing?

The shares were acquired on 08/18/2025 under a Performance Stock Program Award from The Procter & Gamble Company.

What is the aggregate market value reported for the proposed sale?

The aggregate market value is reported as $1,655,314.83.

Which broker is handling the proposed sale in the Form 144?

The broker listed is Morgan Stanley Smith Barney LLC Executive Financial Services, 1 New York Plaza, 38th Floor, New York, NY.